GOLDMAN SACHS GROUP INC - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 111 filers reported holding DICE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 11.16 and the average weighting 1.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$33,313,632
+637.7%
717,039
+354.9%
0.01%
+600.0%
Q1 2023$4,515,727
-15.4%
157,617
-7.8%
0.00%0.0%
Q4 2022$5,335,418
+521.1%
171,007
+303.7%
0.00%
Q3 2022$859,000
+290.5%
42,361
+199.4%
0.00%
Q2 2022$220,000
-11.6%
14,150
+8.6%
0.00%
Q1 2022$249,000
-80.5%
13,035
-66.6%
0.00%
Q3 2021$1,277,00039,0000.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 268,346$12,467,35521.26%
New Leaf Venture Partners, L.L.C. 371,693$17,268,85714.83%
RA Capital Management 7,856,612$365,018,1946.89%
NEXPOINT ASSET MANAGEMENT, L.P. 717,322$33,326,7804.86%
ALPINE ASSOCIATES MANAGEMENT INC. 2,116,800$98,346,5284.43%
KRYGER CAPITAL Ltd 880,756$40,919,9244.18%
Versor Investments LP 436,935$20,300,0003.52%
Crabel Capital Management, LLC 161,082$7,4843.09%
Twin Securities, Inc. 91,680$4,259,0002.36%
Vazirani Asset Management LLC 30,000$1,393,8002.35%
View complete list of DICE THERAPEUTICS INC shareholders